Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Wirestock raises 3M to supply creative multimodal data to AI labs

From TechCrunch

By

May 14, 2026

Wirestock raises 3M to supply creative multimodal data to AI labs

Wirestock raises 3M to supply creative multimodal data to AI labs
Wirestock, a platform connecting creative professionals with AI companies, has raised 3 million in Series A funding led by Nava Ventures. The round also included participation from SBVP, Formula VC, and I2BF Ventures. The company reports 700,000+ creators on its platform, 50 million assets, and 0 million in annualized revenue.

View original article on techcrunch.com

Most Recent

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova has raised at an $11 billion valuation months after Intel was rumored to be trying to buy it for about $1.6 billion.

Jul 8, 2026

EarnOS Secures $18.5M

EarnOS Secures $18.5M

EarnOS announced $18.5 million in strategic funding and the official launch of its ero app across the United States, Canada, Australia and the United Kingdom. The financing includes a $6 million Pre-Series A led by 1kx and a four-year $12.5 million non-dilutive strategic investment from Verona.

Jun 22, 2026

Connie Health raised $40M Series B led by HealthQuest Capital

Connie Health raised $40M Series B led by HealthQuest Capital

Connie Health, a Boston-based AI-native Medicare navigation platform, has raised $40 million in Series B funding led by HealthQuest Capital to accelerate acquisitions, AI development, and value-based care partnerships.

Jun 21, 2026

Connie Health Raises $40M Series B

Connie Health Raises $40M Series B

Connie Health raises $40M Series B led by HealthQuest Capital to scale its AI-native Medicare navigation platform and expand its agent network, bringing total funding to $85M.

Jun 20, 2026

Similar Posts

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova has raised at an $11 billion valuation months after Intel was rumored to be trying to buy it for about $1.6 billion.

Jul 8, 2026

Exaforce raises $125M Series B to build AI for catching and stopping cyberattacks

Exaforce raises $125M Series B to build AI for catching and stopping cyberattacks

Exaforce has raised $125 million in Series B funding at a $725 million post-money valuation to scale its agentic SOC platform.

May 11, 2026

ElevenLabs lists BlackRock, Jamie Foxx, and Eva Longoria as new investors

ElevenLabs lists BlackRock, Jamie Foxx, and Eva Longoria as new investors

ElevenLabs reveals new investors, hits $500M ARR, and expands enterprise footprint as voice AI becomes a critical interface.

May 5, 2026

Deepgram raises $130M at $1.3B valuation and buys a YC AI startup

Deepgram raises $130M at $1.3B valuation and buys a YC AI startup

Deepgram raises $130 million in a Series C round led by AVP at a $1.3 billion valuation, and acquires Y Combinator-backed OfOne.

Jan 13, 2026

Most Recent

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova has raised at an $11 billion valuation months after Intel was rumored to be trying to buy it for about $1.6 billion.

Jul 8, 2026

EarnOS Secures $18.5M

EarnOS Secures $18.5M

EarnOS announced $18.5 million in strategic funding and the official launch of its ero app across the United States, Canada, Australia and the United Kingdom. The financing includes a $6 million Pre-Series A led by 1kx and a four-year $12.5 million non-dilutive strategic investment from Verona.

Jun 22, 2026

Connie Health raised $40M Series B led by HealthQuest Capital

Connie Health raised $40M Series B led by HealthQuest Capital

Connie Health, a Boston-based AI-native Medicare navigation platform, has raised $40 million in Series B funding led by HealthQuest Capital to accelerate acquisitions, AI development, and value-based care partnerships.

Jun 21, 2026

Connie Health Raises $40M Series B

Connie Health Raises $40M Series B

Connie Health raises $40M Series B led by HealthQuest Capital to scale its AI-native Medicare navigation platform and expand its agent network, bringing total funding to $85M.

Jun 20, 2026

Similar Posts

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova raises $1B at $11B valuation, 5 months after last mega round

AI chip maker SambaNova has raised at an $11 billion valuation months after Intel was rumored to be trying to buy it for about $1.6 billion.

Jul 8, 2026

Exaforce raises $125M Series B to build AI for catching and stopping cyberattacks

Exaforce raises $125M Series B to build AI for catching and stopping cyberattacks

Exaforce has raised $125 million in Series B funding at a $725 million post-money valuation to scale its agentic SOC platform.

May 11, 2026

ElevenLabs lists BlackRock, Jamie Foxx, and Eva Longoria as new investors

ElevenLabs lists BlackRock, Jamie Foxx, and Eva Longoria as new investors

ElevenLabs reveals new investors, hits $500M ARR, and expands enterprise footprint as voice AI becomes a critical interface.

May 5, 2026

Deepgram raises $130M at $1.3B valuation and buys a YC AI startup

Deepgram raises $130M at $1.3B valuation and buys a YC AI startup

Deepgram raises $130 million in a Series C round led by AVP at a $1.3 billion valuation, and acquires Y Combinator-backed OfOne.

Jan 13, 2026